|
Volumn 105, Issue 2, 2011, Pages 327-328
|
Stability of BRAF V600E mutation in metastatic melanoma: New insights for therapeutic success
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
B RAF KINASE INHIBITOR;
CANCER CELL CULTURE;
CANCER GROWTH;
CANCER RECURRENCE;
CANCER RESISTANCE;
CANCER STAGING;
DNA MODIFICATION;
GENE FREQUENCY;
GENE MUTATION;
GENETIC HETEROGENEITY;
GENOTYPE;
HOMOZYGOSITY;
HUMAN;
LETTER;
MELANOMA;
METASTASIS;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROTEIN STABILITY;
PYROSEQUENCING;
SINGLE NUCLEOTIDE POLYMORPHISM;
SKIN CANCER;
SKIN MELANOMA;
AMINO ACID SUBSTITUTION;
DISEASE PROGRESSION;
GLUTAMIC ACID;
HUMANS;
MELANOMA;
MUTATION, MISSENSE;
NEOPLASM METASTASIS;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS B-RAF;
SELECTION, GENETIC;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
VALINE;
|
EID: 79960236564
PISSN: 00070920
EISSN: 15321827
Source Type: Journal
DOI: 10.1038/bjc.2011.239 Document Type: Letter |
Times cited : (14)
|
References (5)
|